Edition:
India

People: Exact Sciences Corp (EXAS.OQ)

EXAS.OQ on NASDAQ Stock Exchange Capital Market

106.87USD
1:30am IST
Change (% chg)

$2.46 (+2.36%)
Prev Close
$104.41
Open
$104.54
Day's High
$107.55
Day's Low
$104.50
Volume
349,146
Avg. Vol
538,112
52-wk High
$123.94
52-wk Low
$53.09

Conroy, Kevin 

Mr. Kevin T. Conroy is Chairman of the Board, President, Chief Executive Officer of the Company. Mr. Conroy has served as our President and Chief Executive Officer since April 2009, as a director since March 2009 and as Chairman of our Board of Directors since March 2014. Mr. Conroy served as president and chief executive officer of Third Wave Technologies, Inc., a molecular diagnostics company, from December 2005 until the acquisition of Third Wave by Hologic, Inc. in July 2008. He joined Third Wave in July 2004 and served as general counsel until December 2005. Prior to joining Third Wave, Mr. Conroy held leadership positions at GE Healthcare and practiced intellectual property law in private practice. Mr. Conroy also serves as a director of Epizyme, Inc., a clinical-stage biopharmaceutical company (NASDAQ: EPZM). He earned a bachelor's degree in electrical engineering at Michigan State University and a JD from the University of Michigan.

Basic Compensation

Total Annual Compensation, USD 1,490,750
Restricted Stock Award, USD 3,651,650
Long-Term Incentive Plans, USD --
All Other, USD 1,849,590
Fiscal Year Total, USD 6,992,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 500,843 27,760,500.00
Name Fiscal Year Total

Kevin Conroy

6,992,000

Jeffrey Elliott

1,983,860

Mark Stenhouse

3,862,260

D. Scott Coward

2,085,310

Graham Lidgard

2,084,980

Ana Hooker

--
As Of  31 Dec 2018